Biocon Ltd.’s consolidated web revenue fell 84.3% within the second quarter of fiscal 2025, lacking analysts’ estimates.
The drugmaker’s revenue declined to Rs 27.1 crore within the September quarter, as in comparison with Rs 172.7 crore within the year-ago interval, in response to an trade submitting on Wednesday. That compares with the Rs 24-crore consensus estimate of analysts tracked by Bloomberg.
The IDF Spokesperson announced Wednesday morning that there had been an historic event in the skies over Tehran. An...
Gen X is expected to consume over $500 billion worth of goods and services by FY30 fuelling demand for various...
The Government of India is working on a plan to bring its separate tax and financial reporting regimes under a...
The consumer discretionary space continues to reveal a mixed performance across segments, driven by gold prices, festive shifts, and evolving...
Sir Demis Hassabis is Co-Founder and CEO of Google DeepMind. He has won many prestigious international awards for his research work...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
